Trial resumes for French slimming drug Mediator

A box of the drug Mediator. Producers of the drug are currently on trial in France as it is thought to have caused the death of hundreds of people.
Mediator is thought to cause severe heart problems. The drug was prescribed as a treatment for type 2 diabetes and weight-loss.

A trial into the deaths of hundreds of people in France suspected to have been caused by weight-loss drug Mediator, has resumed after an 11-week pause due to confinement.

The case against Servier, the pharmaceutical company that produced the drug, was brought by 2,600 plaintiffs and involves hundreds of lawyers. It is suggested that the drug Mediator allegedly causes serious heart damage, and may be linked to the deaths of up to 2,100 people.

The case has resumed in Paris (Ile-de-France), with physical distancing measures in place.

Read more: Mediator drug trial begins in France

Read more: Film for French doctor who blew whistle on fatal slimming pill ...

To read the remaining 85% of this article, you need to either

Subscribe now to The Connexion and benefit from access to our archived articles since 2006

Print + Digital 3 month subscription

Pay every three months. Our most flexible subscription.

Automatic renewal, cancel anytime

€14.25 to France - €18 to EU/UK - €19.50 to rest of the world per quarter including postage

Print + Digital 1 year subscription

1 year of great reading in print and online

Automatic renewal, cancel anytime

€55 to France - €70 to EU/UK - €76 to rest of the world per year including postage

Digital 1 year subscription (Our best value offer)

1 year of great reading online *no paper*

Automatic renewal, cancel anytime

Digital 3 month subscription

3 months of great reading online *no paper*

Automatic renewal, cancel anytime

More articles from French news
More articles from Connexion France
Other articles that may interest you